Peak Performance Bone & Joint Pack Women's (Vitality Multivitamin & Mineral component)
Natural health product licensed in Canada
If this product were sold in France
- Conditions légales
Contains tea (Camellia sinensis). Green tea extracts must provide less than 800 mg of epigallocatechin-3-gallate per daily portion, with mandatory warnings.
annexe III, partie B (règlement (UE) 2022/2340). Regulation (EC) No 1925/2006, latest consolidated version, retrieved 21 October 2026, source updated 26 November 2025.
- Conditions légales
Camellia sinensis (L.) Kuntze: Seules sont admises la poudre issue du broyage des feuilles et les préparations obtenues à partir des solvants suivants : l'eau, l'alcool à 25 % (v/v), ainsi que les solvants autorisés pour la décaféination ou la suppression des matières irritantes et amères. Les recommandations d'emploi ne doivent pas conduire à une ingestion quotidienne d'EGCG supérieure à 300 mg. L'étiquetage doit comporter des avertissements déconseillant leur prise en dehors des repas, ainsi que leur consommation par les enfants, les adolescents, les femmes enceintes ou allaitantes.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Ginkgo biloba L.: L'étiquetage des compléments alimentaires qui contiennent la feuille de la plante Ginkgo biloba L. doit comporter un avertissement avec la teneur suivante: "Consultez votre médecin en cas de prise simultanée d'anticoagulants."
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| 3,3',4',5,7-Pentahydroxyflavone Source : Quercétine dihydraté | 22.5 mg | Not calculated |
| 3,3',4',5,7-Pentahydroxyflavone Source : Styphnolobium japonicum - Bourgeon floral | 22.5 mg | Not calculated |
| Lycopène Source : Lycopène | 1.5 mg | Not calculated |
| Calcium Source : Calcium aspartate | 250 mg | Not calculated |
| Calcium Source : Phosphate de calcium, dibasique | 250 mg | Not calculated |
| Calcium Source : Diglycinate de calcium | 250 mg | Not calculated |
| Calcium Source : Sulfate de calcium | 250 mg | Not calculated |
| Calcium Source : Citrate de calcium | 250 mg | Not calculated |
| Calcium Source : Calcium carbonate | 250 mg | Not calculated |
| Manganèse Source : Aspartate de manganèse (II) | 1.25 mg | Not calculated |
| Manganèse Source : Sulfate de manganèse (II) | 1.25 mg | Not calculated |
| Magnésium Source : Aspartate de magnésium | 50 mg | Not calculated |
| Magnésium Source : Bisglycinate de magnésium | 50 mg | Not calculated |
| Magnésium Source : Sulfate de magnésium | 50 mg | Not calculated |
| Magnésium Source : Oxyde de magnésium | 50 mg | Not calculated |
| Curcuma longa Source : Curcuma longa - rhizome Extraction ratio : 25:1 Dry plant equivalent : 52.5 mg | 2.1 mg | Not calculated |
| Cuivre Source : Diglycinate de cuivre (II) | 1.5 mg | Not calculated |
| Cuivre Source : Sulfate de cuivre (II) | 1.5 mg | Not calculated |
| Vitamine C Source : Acide ascorbique | 150 mg | Not calculated |
| Vitamine D Source : Cholécalciférol | 2.5 mcg | Not calculated |
| Zinc Source : Sulfate de zinc | 7.5 mg | Not calculated |
| Zinc Source : Aspartate de zinc | 7.5 mg | Not calculated |
| Vitis vinifera Source : Vitis vinifera - Graine Extract : Matériel brut sec Extraction ratio : 10:1 Dry plant equivalent : 125 % Potency : 95 % Proanthocyanidins | 12.5 mg | Not calculated |
| Lactobacillus plantarum Source : Lp-115 | 2 Milliards d'UFC | Not calculated |
| Lactobacillus plantarum Source : Lactobacillus plantarum - Cellule entière | 2 Milliards d'UFC | Not calculated |
| Lactobacillus casei Source : Lactobacillus casei - Cellule entier (Souche ATCC-393) | 1.5 Milliards d'UFC | Not calculated |
| Lactobacillus casei Source : LC-11 | 1.5 Milliards d'UFC | Not calculated |
| Papaïne Source : Carica papaya - feuille | 1,750 Unités de papaïne du FCC | Not calculated |
| Papaïne Source : Carica papaya - fruit | 1,750 Unités de papaïne du FCC | Not calculated |
| Papaïne Source : Carica papaya - feuille | 3.33 mg | Not calculated |
| Papaïne Source : Carica papaya - fruit | 3.33 mg | Not calculated |
| Manganèse Source : Sulfate de manganèse (II) | 0.667 mg | Not calculated |
| Manganèse Source : Diglycinate de manganèse (II) | 0.667 mg | Not calculated |
| Manganèse Source : Aspartate de manganèse (II) | 0.667 mg | Not calculated |
| Acide pantothénique Source : D-Pantothénate de calcium | 10 mg | Not calculated |
| Curcuma longa Source : Curcuma longa - rhizome Extract : Matériel brut sec Extraction ratio : 25:1 Dry plant equivalent : 1,250 mg | 50 mg | Not calculated |
| Trans-resvératrol Source : Reynoutria Japonica - racine | 12 mg | Not calculated |
| Zingiber officinale Source : Zingiber officinale - Rhizome Extract : Matériel brut sec Extraction ratio : 10-15:1 Dry plant equivalent : 1000-1500 mg | 100 mg | Not calculated |
| Bromélaïne de tige Source : Ananas comosus var. comosus - Tige | 165 Unités de papaïne du FCC | Not calculated |
| Biotine Source : Biotine | 150 mcg | Not calculated |
| Vitamine C Source : Acide ascorbique | 75 mg | Not calculated |
| Folate Source : L-5 Méthyltétrahydrofolate, sel de calcium | 400 mcg | Not calculated |
| Calcium Source : Calcium carbonate | 37.5 mg | Not calculated |
| Huile de poisson Source : Scombridae - en entier Potency : 500 mg Eicosapentaenoic acid | 1 g | Not calculated |
| Huile de poisson Source : Clupeidae - en entier Potency : 500 mg Eicosapentaenoic acid | 1 g | Not calculated |
| Huile de poisson Source : Engraulidae - en entier Potency : 500 mg Eicosapentaenoic acid | 1 g | Not calculated |
| Huile de poisson Source : Scombridae - en entier Potency : 50 mg Docosahexaenoic acid | Not specified | Not calculated |
| Huile de poisson Source : Clupeidae - en entier Potency : 50 mg Docosahexaenoic acid | Not specified | Not calculated |
| Huile de poisson Source : Engraulidae - en entier Potency : 50 mg Docosahexaenoic acid | Not specified | Not calculated |
| Aronia melanocarpa Source : Aronia melanocarpa (chokeberry), Fruit Extract : Matériel brut sec Extraction ratio : 10:1 Dry plant equivalent : 75 mg | 7.5 mg | Not calculated |
| Molybdène Source : Aspartate de molybdène (VI) | 37.5 mcg | Not calculated |
| Molybdène Source : Molybdate de sodium (VI) | 37.5 mcg | Not calculated |
| Bifidobacterium animalis subsp. lactis Source : Bifidobacterium animalis subsp. lactis- Cellule entière | 1.8 Milliards d'UFC | Not calculated |
| Bifidobacterium animalis subsp. lactis Source : BL-04 | 1.8 Milliards d'UFC | Not calculated |
| Griffe du diable Source : Harpagophytum zeyheri - Secondary root tuber Extract : Matériel brut sec Extraction ratio : 3-5:1 Dry plant equivalent : 300-500 mg | 100 mg | Not calculated |
| Griffe du diable Source : Harpagophytum procumbens - Secondary root tuber Extract : Matériel brut sec Extraction ratio : 3-5:1 Dry plant equivalent : 300-500 mg | 100 mg | Not calculated |
| Vitis vinifera Source : Vitis vinifera - Fruit Extract : Matériel brut sec Extraction ratio : 200:1 Dry plant equivalent : 1,800 mg Potency : 10 % anthocyanins | 9 mg | Not calculated |
| Vitis vinifera Source : Quercétine dihydraté Extract : Matériel brut sec Extraction ratio : 200:1 Dry plant equivalent : 1,800 mg Potency : 10 % anthocyanins | 9 mg | Not calculated |
| Vitamine C Source : Acide ascorbique | 60 mg | Not calculated |
| Olea europaea Source : Olea europaea - Fruit Extract : Matériel brut sec Extraction ratio : 11-14:1 Dry plant equivalent : 825-1050 mg | 75 mg | Not calculated |
| Griffe du diable Source : Harpagophytum zeyheri - Secondary root tuber Extraction ratio : 3-5:1 Dry plant equivalent : 50.1-83.5 mg | 16.7 mg | Not calculated |
| Camellia sinensis Source : Camellia sinensis - feuille Extract : Matériel brut sec Extraction ratio : 5-8:1 Dry plant equivalent : 66.5-106.4 mg Potency : 15 % Polyphenols | 13.3 mg | Not calculated |
| Vaccinium myrtillus Source : Vaccinium myrtillus - Fruit Extract : Matériel brut sec Extraction ratio : 80-130:1 Dry plant equivalent : 20-32.5 mg Potency : 36 % Anthocyanins | 0.25 mg | Not calculated |
| Ginkgo biloba Source : Ginkgo biloba - feuille Extract : Matériel brut sec Extraction ratio : 50:1 Dry plant equivalent : 12.5 mg Potency : 24 % Flavonoid glycosides | 0.25 mg | Not calculated |
| Ginkgo biloba Source : Ginkgo biloba - feuille Potency : 6 % Terpene lactones | Not specified | Not calculated |
| Camellia sinensis Source : Camellia sinensis - feuille Extraction ratio : 15-20:1 Dry plant equivalent : 750-1000 mg Potency : 85 % Polyphenols | 50 mg | Not calculated |
| Chlorhydrate de 2-amino-2-désoxy-bêta-D-glucopyranose Source : Exosquelette de crevette | 500 mg | Not calculated |
| Chlorhydrate de 2-amino-2-désoxy-bêta-D-glucopyranose Source : Exosquelette de crabe | 500 mg | Not calculated |
| Chlorhydrate de 2-amino-2-désoxy-bêta-D-glucopyranose Source : exosquelettes de homards | 500 mg | Not calculated |
| Chlorhydrate de 2-amino-2-désoxy-bêta-D-glucopyranose Source : Exosquelette du krill | 500 mg | Not calculated |
| Chlorhydrate de 2-amino-2-désoxy-bêta-D-glucopyranose Source : exosquelettes de crevettes | 500 mg | Not calculated |
| Griffe du diable Source : Harpagophytum procumbens - Secondary root tuber Extraction ratio : 3-5:1 Dry plant equivalent : 50.1-83.5 mg | 16.7 mg | Not calculated |
| Zingiber officinale Source : Zingiber officinale - Rhizome Extraction ratio : 10-15:1 Dry plant equivalent : 30-45 mg | 3 mg | Not calculated |
| Bromélaïne de tige Source : Ananas comosus var. comosus - Tige | 24,000 Unités de papaïne du FCC | Not calculated |
| Bromélaïne de tige Source : Ananas comosus var. comosus - Tige | 13.3 mg | Not calculated |
| Sulfate de chondroïtine Source : Bos taurus - cartilage | 83.3 mg | Not calculated |
| Sulfate de chondroïtine Source : Sus scrofa (cartilage) | 83.3 mg | Not calculated |
| Sulfate de chondroïtine Source : Gallus gallus - cartilage | 83.3 mg | Not calculated |
| Sulfone de diméthyl Source : Sulfone de diméthyl | 166.7 mg | Not calculated |
| Vitamine D Source : Cholécalciférol | 400 UI | Not calculated |
| Vitamine D Source : Cholécalciférol | 200 UI | Not calculated |
| Bêta-carotène Source : bêta-carotène | 1,500 UI | Not calculated |
| Vitamine E Source : Succinate d'acide de d-alpha tocophéryle | 15 UI | Not calculated |
| Calcium Source : Gluconate de calcium | 125 mg | Not calculated |
| Calcium Source : Calcium aspartate | 125 mg | Not calculated |
| Calcium Source : Calcium carbonate | 125 mg | Not calculated |
| Calcium Source : Chlorure de calcium | 125 mg | Not calculated |
| Calcium Source : Citrate de calcium | 125 mg | Not calculated |
| Calcium Source : Diglycinate de calcium | 125 mg | Not calculated |
| Sélénium Source : Sélénite de sodium | 52.5 mcg | Not calculated |
| Sélénium Source : Aspartate de sélénium | 52.5 mcg | Not calculated |
| Extrait de pépins de raisin Source : Vitis vinifera - Graine Extract : Matériel brut sec Extraction ratio : 10-15:1 Dry plant equivalent : 630-945 mg Potency : 80 % Oligomeric proanthocyanidins | 63 mg | Not calculated |
| Fer Source : Aspartate de fer (II) | 4.5 mg | Not calculated |
| Fer Source : Sulfate de fer (II) | 4.5 mg | Not calculated |
| Magnésium Source : Lactate de magnésium | 100 mg | Not calculated |
| Magnésium Source : Oxyde de magnésium | 100 mg | Not calculated |
| Magnésium Source : Sulfate de magnésium | 100 mg | Not calculated |
| Magnésium Source : Citrate de magnésium | 100 mg | Not calculated |
| Magnésium Source : Aspartate de magnésium | 100 mg | Not calculated |
| Magnésium Source : Bisglycinate de magnésium | 100 mg | Not calculated |
Non-medicinal ingredients
Acide stéarique, Vanilline, Cire de Carnauba, Maltodextrine, Stéarate de magnésium, Amidon de maïs, Cellulose microcristalline, Dioxyde de titane, Carraghénine, Hydroxypropyl méthylcellulose, Riboflavine, Extrait de romarin, Sorbitol, Saveur, Gélatine, Gomme de gellane, Huile de carthame, Hydroxyde de sodium, Acide ascorbique, Inuline, Hydroxypropylcellulose, Palmitate d'ascorbyle, Fructooligosaccharides, Spirulina platensis whole, Eau, Caramel, Dioxyde de silicium, Croscarmellose de sodium, Mélange de concentré de tocophérols, Acide citrique, Glycérine, citrate de sodium, Lécithine, Huile de tournesol, Poly(éthylène glycol)
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 1 Comprimé | 2 Tous les jours |
Uses authorised in Canada
Helps to maintain healthy cartilage/joint health. Helps to maintain healthy hair, nail, mucous membranes and/or skin. Helps to maintain healthy metabolism. Helps to maintain healthy mucous membranes. Helps to maintain healthy skin. Helps to maintain heart muscle function. Helps to maintain normal blood glucose levels. Helps to maintain normal electrolyte balance. Helps to maintain normal function of the thyroid gland. Helps to maintain normal iron transport in the body. Helps to maintain normal metabolism of iron. Helps to maintain normal muscle function. Helps to maintain normal red blood cells. Helps to maintain proper muscle function, including the heart muscle. Helps to maintain the body's ability to metabolize nutrients. Helps to maintain the body's ability to metabolize nutrients and helps in tissue formation. Helps to produce and repair connective tissue. Helps to relieve symptoms related to non-complicated chronic venous insufficiency (CVI), such as sensation of swelling, heaviness and tingling of the legs. Helps with immune function. Maintains healthy hair, skin and nails. Maintains good health. Mineral supplement. Multi-mineral supplement. Multi-vitamin and multi-mineral supplement. Multi-vitamin supplement. Provides/Source of/An electrolyte (for the maintenance of good health). Provides support for healthy glucose metabolism. Provitamin A/Source of vitamin A for the maintenance of good health. Provitamin A/Source of vitamin A to help/helps in the development and maintenance of bones and teeth. Provitamin A/Source of vitamin A to help/helps in the development and maintenance of night vision. Provitamin A/Source of vitamin A to help/helps in the development and maintenance of night vision, bones and teeth. Provitamin A/Source of vitamin A to help/helps maintain eyesight, skin, membranes and immune function. Provitamin A/Source of vitamin A to help/helps maintain eyesight, skin, membranes and immune function and helps in the development and maintenance of night vision, bones and teeth. Source of/An antioxidant for the maintenance of good health. Source of/An antioxidant that helps (to): a) fight / b) protect (cells) against / c) reduce (the oxidative effect of/the oxidative damage caused by/cell damage caused by) free radicals. Source of/An antioxidant that helps fight/protect (cell) against/reduce (the oxidative effect of/the oxidative damage caused by/cell damage caused by) free radicals. Source of/An antioxidant that helps protect against oxidative stress. Source of/An antioxidant that protects the fat in body tissues from oxidation. Source of antioxidant(s)/Provides antioxidant(s). Source of antioxidant(s)/Provides antioxidant(s) that help(s) fight/protect (cell) against/reduce (the oxidative effect of/the oxidative damage caused by/cell damage caused by) free radicals. Source of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) for the maintenance of good health. Source of probiotics. Source of omega-3 fatty acids for the maintenance of good health. Source of vitamin(s)/mineral(s)/vitamin(s) and mineral(s), a factor/factors in normal growth and development. Source of vitamin(s)/mineral(s)/vitamin(s) and mineral(s), a factor/factors in the maintenance of good health. Source of vitamin(s)/mineral(s)/vitamin(s) and mineral(s) to support biological functions which play a key role in the maintenance of good health. Supports energy production. Supports good health. Turmeric is (traditionally) used in Herbal Medicine as an anti-inflammatory to help relieve joint pain. Turmeric is traditionally used in Ayurveda to relieve pain and inflammation. Vitamin and mineral supplement. Vitamin supplement.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Product record
- Other names
- Peak Performance Bone & Joint Pack for Women
- Licence holder
- Melaleuca of Canada Inc.
- NPN or DIN-HM
- 80097959
- Status
- Active licence
- Licence date
- 29 March 2020
- Revision date
- 30 November 2021
- Form
- Kit
- Route of administration
- Orale
- Application type
- Non traditionnelle
Source
Official Health Canada record, licence 80097959
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Curcuma longa
Read the warning, when it applies and the studies cited
TURMERIC - CURCUMA LONGA - Oral
Route of administration: Oral (ESCOP 2003; Blumenthal et al. 2000)
Cautions and warnings
Condition of application: All products.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (ESCOP 2003; Brinker 2001; McGuffin et al. 1997).
Sources cited by Health Canada (2)
- ESCOP: ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products, 2nd edition. Exeter (GB): European Scientific Cooperative on Phytotherapy and Thieme; 2003.
- McGuffin M, Hobbs C, Upton R, Goldberg A, editors. American Herbal Products Association's Botanical Safety Handbook. Boca Raton (FL): CRC Press; 1997.
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have a liver or biliary disorder (HC 2025; EMA 2018; Brinker 2010; ESCOP 2003; McGuffin et al. 1997).
Sources cited by Health Canada (6)
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- EMA 2018. European Medicines Agency. European Union herbal monograph on Curcuma longa L., rhizome. London (GB): EMA Committee on Herbal Medicinal Products (HMPC); 25 September 2018. [Accessed 2023 October 14] Available from: https://www.ema.europa.eu/en/documents/herbal-monograph/final-european-union-herbal-monograph-curcuma-longa-l-rhizoma-revision-1_en.pdf
- ESCOP: ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products, 2nd edition. Exeter (GB): European Scientific Cooperative on Phytotherapy and Thieme; 2003.
- HC 2025: Health Canada: Summary Safety Review - Turmeric and Curcuminoids for Oral Use - Assessing the Potential Risk of Hepatotoxicity. Available from: https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR1758121117867
- McGuffin M, Hobbs C, Upton R, Goldberg A, editors. American Herbal Products Association's Botanical Safety Handbook. Boca Raton (FL): CRC Press; 1997.
- SC 2025: Santé Canada : Résumé de l'examen de l'innocuité - Curcuma et curcuminoïdes pour usage oral - Évaluation du risque potentiel d'hépatotoxicité. Disponible à : https://pmps.hpfb-dgpsa.ca/documents-d-examen/ressource/SSR1758121117867
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking medications (HC 2025).
Sources cited by Health Canada (2)
- HC 2025: Health Canada: Summary Safety Review - Turmeric and Curcuminoids for Oral Use - Assessing the Potential Risk of Hepatotoxicity. Available from: https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR1758121117867
- SC 2025: Santé Canada : Résumé de l'examen de l'innocuité - Curcuma et curcuminoïdes pour usage oral - Évaluation du risque potentiel d'hépatotoxicité. Disponible à : https://pmps.hpfb-dgpsa.ca/documents-d-examen/ressource/SSR1758121117867
Stop use and ask a health care practitioner/health care provider/health care professional/doctor/physician if you experience any new symptoms including yellowing of the eyes or skin, dark urine, nausea, vomiting, stomach pain (HC 2025).
Sources cited by Health Canada (2)
- HC 2025: Health Canada: Summary Safety Review - Turmeric and Curcuminoids for Oral Use - Assessing the Potential Risk of Hepatotoxicity. Available from: https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR1758121117867
- SC 2025: Santé Canada : Résumé de l'examen de l'innocuité - Curcuma et curcuminoïdes pour usage oral - Évaluation du risque potentiel d'hépatotoxicité. Disponible à : https://pmps.hpfb-dgpsa.ca/documents-d-examen/ressource/SSR1758121117867
Condition of application: All uses except for Source of antioxidants and Hepatoprotectant.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Health Canada monograph dated 26 September 2025
Turmeric -CURCUMA LONGA - Topical
Cautions and warnings
For external use only.
When using this product avoid contact with eyes. If contact occurs, rinse thoroughly with water.
Stop use and ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms worsen or last (for) more than 7 days.
Keep out of reach of children. If swallowed, call a poison control centre or get medical help right away.
Contraindications
Do not use on deep or puncture wounds, animal bites or serious burns.
- Vitamine D
Read the warning, when it applies and the studies cited
VITAMIN D (>1,000 - 2,500 IU)
Route of administration: Oral
Cautions and warnings
Condition of application: All products except products containing zinc sourced from picolinate requiring a contraindication.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.
Condition of application: All products.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have kidney disorders (NIH 2024; BfR 2020).
Sources cited by Health Canada (2)
- BfR 2020: Vitamin D: consumption of high-dose food supplements is unnecessary; BfR Opinion No 035; 2020. [Accessed 2026March 18]. Available from: https://www.bfr.bund.de/cm/349/vitamin-d-consumption-of-high-dose-food-supplements-is-unnecessary.pdf
- NIH 2024: National Institute of Health: Vitamin D Fact Sheet for Health Professionals; 2024. [Accessed 2026 March 18]. Available from: https://ods.od.nih.gov/factsheets/VitaminD-HealthProfessional/
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking other supplements or products containing vitamin D or vitamin D analogues.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking any medications including antacids, anticonvulsants, digoxin, cholestyramine, colestipol, mineral oil, steroids, statins or thiazide diuretics (NNHPD 2021; BfR 2020).
Sources cited by Health Canada (3)
- BfR 2020: Vitamin D: consumption of high-dose food supplements is unnecessary; BfR Opinion No 035; 2020. [Accessed 2026March 18]. Available from: https://www.bfr.bund.de/cm/349/vitamin-d-consumption-of-high-dose-food-supplements-is-unnecessary.pdf
- NNHPD 2021. Natural and Non-Prescription Health Products Directorate. Internal evidence and HC's product monographs.
- DPSNSO 2021. Direction des produits de santé naturels et sans ordonnance. Preuves internes et monographies de produits internes de SC.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use to determine if you would benefit from additional vitamin D as 15-20 mcg (600-800 IU) of vitamin D per day is an adequate quantity for most individuals.
Applies to products containing vitamin K2.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking blood thinners (NNHPD 2026).
Sources cited by Health Canada (2)
- NNHPD 2026: Natural and Non-Prescription Health Products Directorate. Multi-Vitamin/Mineral Supplements monograph. [Accessed 2026 May 29]. Available from: https://webprod.hc-sc.gc.ca/nhpid-bdipsn/atReq?atid=multi_vitmin_suppl3&lang=eng
- DPSNSO 2026. Direction des produits de santé naturels et sans ordonnance. Monographies des suppléments de multivitamines et minéraux [Consulté le 29 mai 2026]. Disponible à : https://webprod.hc-sc.gc.ca/nhpid-bdipsn/atReq?atid=multi_vitmin_suppl3&lang=fre
Applies to products providing 25-34 mg of zinc per day for adults 18 years or 31-50 mg of zinc per day for adults 19 years and older.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are unsure whether you are taking enough copper as zinc supplementation can cause a copper deficiency (NNHPD 2026).
Sources cited by Health Canada (2)
- NNHPD 2026: Natural and Non-Prescription Health Products Directorate. Multi-Vitamin/Mineral Supplements monograph. [Accessed 2026 May 29]. Available from: https://webprod.hc-sc.gc.ca/nhpid-bdipsn/atReq?atid=multi_vitmin_suppl3&lang=eng
- DPSNSO 2026. Direction des produits de santé naturels et sans ordonnance. Monographies des suppléments de multivitamines et minéraux [Consulté le 29 mai 2026]. Disponible à : https://webprod.hc-sc.gc.ca/nhpid-bdipsn/atReq?atid=multi_vitmin_suppl3&lang=fre
Contraindications
Condition of application: All products.
Do not use if you have hypercalcemia and/or hypercalciuria (NIH 2024; BfR 2020).
Sources cited by Health Canada (2)
- BfR 2020: Vitamin D: consumption of high-dose food supplements is unnecessary; BfR Opinion No 035; 2020. [Accessed 2026March 18]. Available from: https://www.bfr.bund.de/cm/349/vitamin-d-consumption-of-high-dose-food-supplements-is-unnecessary.pdf
- NIH 2024: National Institute of Health: Vitamin D Fact Sheet for Health Professionals; 2024. [Accessed 2026 March 18]. Available from: https://ods.od.nih.gov/factsheets/VitaminD-HealthProfessional/
Applies to products containing zinc sourced from picolinate.
Do not use if you are pregnant or breastfeeding (NNHPD 2026).
Sources cited by Health Canada (2)
- NNHPD 2026: Natural and Non-Prescription Health Products Directorate. Multi-Vitamin/Mineral Supplements monograph. [Accessed 2026 May 29]. Available from: https://webprod.hc-sc.gc.ca/nhpid-bdipsn/atReq?atid=multi_vitmin_suppl3&lang=eng
- DPSNSO 2026. Direction des produits de santé naturels et sans ordonnance. Monographies des suppléments de multivitamines et minéraux [Consulté le 29 mai 2026]. Disponible à : https://webprod.hc-sc.gc.ca/nhpid-bdipsn/atReq?atid=multi_vitmin_suppl3&lang=fre
Known adverse reactions
Condition of application: All products.
Stop use and ask a health care practitioner/health care provider/health care professional/doctor/physician if the following early symptoms of hypercalcemia occur: weakness, fatigue, drowsiness, headache, lack of appetite, dry mouth, metallic taste, nausea, vomiting, vertigo, ringing in the ears, lack of coordination and muscle weakness or if you develop any other symptom (NIH 2024; BfR 2020).
Sources cited by Health Canada (2)
- BfR 2020: Vitamin D: consumption of high-dose food supplements is unnecessary; BfR Opinion No 035; 2020. [Accessed 2026March 18]. Available from: https://www.bfr.bund.de/cm/349/vitamin-d-consumption-of-high-dose-food-supplements-is-unnecessary.pdf
- NIH 2024: National Institute of Health: Vitamin D Fact Sheet for Health Professionals; 2024. [Accessed 2026 March 18]. Available from: https://ods.od.nih.gov/factsheets/VitaminD-HealthProfessional/
Applies to products providing more than 350 mg of magnesium per day.
When using this product you may experience diarrhea (NNHPD 2026).
Sources cited by Health Canada (2)
- NNHPD 2026: Natural and Non-Prescription Health Products Directorate. Multi-Vitamin/Mineral Supplements monograph. [Accessed 2026 May 29]. Available from: https://webprod.hc-sc.gc.ca/nhpid-bdipsn/atReq?atid=multi_vitmin_suppl3&lang=eng
- DPSNSO 2026. Direction des produits de santé naturels et sans ordonnance. Monographies des suppléments de multivitamines et minéraux [Consulté le 29 mai 2026]. Disponible à : https://webprod.hc-sc.gc.ca/nhpid-bdipsn/atReq?atid=multi_vitmin_suppl3&lang=fre
- Zingiber officinale
Read the warning, when it applies and the studies cited
GINGER - ZINGIBER OFFICINALE
Route of administration: Oral
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
- Huile de poisson
Read the warning, when it applies and the studies cited
FISH OIL
Route of administration: Oral
Cautions and warnings
Condition of application: Pain of rheumatoid arthritis.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms worsen.
Condition of application: Healthy mood balance.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have psychological disorders such as anxiety or depression.
- Olea europaea
Read the warning, when it applies and the studies cited
OLIVE LEAF - OLEA EUROPAEA
Route of administration: Oral
Cautions and warnings
Condition of application: All products.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you pregnant or breastfeeding (EMA 2017).
Sources cited by Health Canada (1)
- EMA 2017: European Medicines Agency. European Union herbal monograph on Olea europaea L., folium. [Accessed 2024 November 27]. Available from: https://www.ema.europa.eu/en/documents/herbal-monograph/final-european-union-herbal-monograph-olea-europaea-l-folium-first-version_en.pdf
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have a kidney disorder (EMA 2017).
Sources cited by Health Canada (1)
- EMA 2017: European Medicines Agency. European Union herbal monograph on Olea europaea L., folium. [Accessed 2024 November 27]. Available from: https://www.ema.europa.eu/en/documents/herbal-monograph/final-european-union-herbal-monograph-olea-europaea-l-folium-first-version_en.pdf
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking other diuretics (EMA 2017).
Sources cited by Health Canada (1)
- EMA 2017: European Medicines Agency. European Union herbal monograph on Olea europaea L., folium. [Accessed 2024 November 27]. Available from: https://www.ema.europa.eu/en/documents/herbal-monograph/final-european-union-herbal-monograph-olea-europaea-l-folium-first-version_en.pdf
Known adverse reactions
Condition of application: All products except those making a diuretic claim.
When using this product diuretic effect may occur.
- Vaccinium myrtillus
Read the warning, when it applies and the studies cited
BILBERRY - VACCINIUM MYRTILLUS - Buccal
Route of administration: Buccal (Blumenthal et al. 2000)
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Health Canada monograph dated 30 January 2026
BILBERRY - VACCINIUM MYRTILLUS - Oral
Route of administration: Oral (Blumenthal et al. 2000)
Cautions and warnings
Condition of application: Relief of diarrhea.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Condition of application: Slowing the progression of disorders of the eye and to relieve symptoms related to non-complicated CVI.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms worsen.
- Ginkgo biloba
Read the warning, when it applies and the studies cited
GINKGO - GINKGO BILOBA
Route of administration: Oral
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (Blumenthal et al. 2000; WHO 1999).
Sources cited by Health Canada (3)
- Blumenthal M, Goldberg A, Brinkmann J, editors. Herbal Medicine: Expanded Commission E Monographs. Newton (MA): Integrative Medicine Communications; 2000.
- WHO 1999: World Health Organization. WHO monographs on selected medicinal plants, Volume 1. Geneva (CHE): World Health Organization; 1999.
- OMS 1999 : Organisation mondiale de la santé (OMS). Monographs on selected medicinal plants, Volume 1. Genève (CHE): Organisation mondiale de la santé; 1999.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking diabetes, high blood pressure or seizure medications (Brinker 2010).
Sources cited by Health Canada (1)
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
Contraindications
Do not use if you are having a surgery (Gardner and McGuffin 2013).
Sources cited by Health Canada (1)
- Gardner Z, McGuffin M, editors. American Herbal Products Association's Botanical Safety Handbook. Second Edition. Boca Raton (FL): Taylor and Francis Group; 2013.
Do not use if you are taking blood thinners or other health products that affect blood coagulation (Gardner and McGuffin 2013; Brinker 2010; Bent 2005).
Sources cited by Health Canada (3)
- Bent S, Goldberg H, Padula A, Avins AL. Spontaneous bleeding associated with ginkgo biloba: a case report and systematic review of the literature. Journal of General Internal Medicine 2005;20(7):657-661. PubMed Systematic review
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- Gardner Z, McGuffin M, editors. American Herbal Products Association's Botanical Safety Handbook. Second Edition. Boca Raton (FL): Taylor and Francis Group; 2013.
They concern the ingredient, not this product or its dose. They do not replace medical advice.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “Peak Performance Bone & Joint Pack Women's (Vitality Multivitamin & Mineral component) (Melaleuca of Canada Inc.): composition and ingredients”, https://compoatlas.com/en/supplements/canada/80097959-peak-performance-bone-joint-pack-women-s-vitality-multivitam, updated 30 November 2021.